drugset / Trial / NCT04869709

Late Preterm Corticosteroids and Neonatal Hypoglycemia

NCT04869709

Phase 4 Unknown 210 enrolled University of Southern California
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective randomized controlled trial investigating the timing of betamethasone administration in late preterm infants in relation to delivery and impact on neonatal hypoglycemia. Previous data has shown that neonatal hypoglycemia is increased in late preterm infants that were exposed to antenatal corticosteroids. The investigators hypothesize that the timing of steroid administration may impact the development of neonatal hypoglycemia.

Timeline

Start
2021-07
Primary completion
2023-07
Completion
2024-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified 12 mg Intramuscular

Indications

No indication recorded.